[{"Assets_0_Q2_USD":308763000.0,"CommonStockSharesOutstanding_0_Q2_shares":34118994.0,"EarningsPerShareBasic_1_Q2_USD":0.25,"EarningsPerShareBasic_2_Q2_USD":0.34,"EarningsPerShareDiluted_2_Q2_USD":0.33,"EarningsPerShareDiluted_1_Q2_USD":0.24,"NetIncomeLoss_1_Q2_USD":8438000.0,"NetIncomeLoss_2_Q2_USD":11506000.0,"StockholdersEquity_0_Q2_USD":190943000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":35094814.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":34715797.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":34097805.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":33995323.0,"Ticker":"RGEN","CIK":"730272","name":"REPLIGEN CORP","OfficialName":"Repligen Corporation Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8540516807.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]